Erschienen in:
11.10.2018 | ASO Author Reflections
ASO Author Reflections: Improving Identification of Intraductal Papillary Mucinous Neoplasm Patients at Risk—Current Status and the Role of IPMN Molecular Biomarkers
verfasst von:
Ajay V. Maker, MD
Erschienen in:
Annals of Surgical Oncology
|
Sonderheft 3/2018
Einloggen, um Zugang zu erhalten
Excerpt
Within our generation, we have witnessed an evolution of surgery for cystic lesions of the pancreas, particularly intraductal papillary mucinous neoplasms (IPMNs). Recommendations for surgical resection have progressed from resection of all lesions to resection of only selected IPMNs based on an estimation of malignant risk. Since the characterization and terminology of what constitutes an IPMN has evolved over the last 22 years since the WHO definition, the reported incidence of malignancy in surgically treated patients has fluctuated based on the time period of reporting. The purpose of the current study was to create a snapshot of the rate of malignancy in resected IPMNs that is reflective of the current surgical era post-establishment of recent international consensus guidelines. …